Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICELAND: Intermittent vs Continuous ELIGARD in Prostate Cancer
NCT00378690Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Mar 2006
- Primary completion
- Jun 2011
- Modality
- Peptides, Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of leuprolide in prostate cancer (PCa), sponsored by Astellas Pharma. Started Mar 2006; status: completed.
02
Drugs
leuprolide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00378690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00378690.